New Stock News | BenQ Hospital's Listing in Hong Kong Approved by China Securities Regulatory Commission

On January 21, the China Securities Regulatory Commission issued a notice on the filing for overseas issuance and listing of BenQ BM Holding Cayman Corp. (BenQ Hospital Group Limited). BenQ Hospital plans to issue no more than 93,895,500 shares of overseas listed common stock and list on the Hong Kong Stock Exchange. According to the prospectus submitted at the time of filing, BenQ Hospital, drawing on advanced hospital operation and management experience from Taiwan, is a pioneer and leader in private-profit comprehensive hospital groups in mainland China. The company currently owns and operates two comprehensive hospitals. According to Frost & Sullivan data, based on revenue generated from medical services in 2022, BenQ Hospital is the largest private-profit comprehensive hospital group in the East China region, with revenue surpassing the combined total of the second and third. Based on the same criteria, among all private-profit comprehensive hospital groups in the country, BenQ Hospital ranks fifth and is the only group among the top five whose hospitals are all third-level hospitals. Based on average revenue per registered bed in 2022, BenQ Hospital ranks first among all private-profit comprehensive hospital groups in mainland China. As of December 31, 2023, the total operating area of BenQ Hospital's two hospitals is approximately 380,000 square meters, with a total of 1,850 registered beds and a doctor team of over 900 people, including 35 experts from Taiwan and overseas. In 2023, the company had over 2 million outpatient visits and performed over 20,000 inpatient surgeries. BenQ Hospital operates two comprehensive hospitals, Nanjing BenQ Hospital and Suzhou BenQ Hospital. In terms of finances, in the financial years of 2021, 2022, and 2023, the company achieved operating revenues of approximately RMB 2.224 billion, 2.336 billion, and 2.688 billion respectively. Meanwhile, the company's annual profits were approximately RMB 69.075 million, 89.55 million, and 167 million respectively during the same period.